HOME >> BIOLOGY >> NEWS
Enzyme delivered in smaller package protects cells from radiation damage

SEATTLE, June 1 A University of Pittsburgh School of Medicine research team, collaborating with scientists from Stanford University, have developed a new, smaller gene therapy vector that may be effective in delivering a radioprotective enzyme systemically throughout the body which may spare healthy tissue the long-term consequences of therapeutic irradiation. These results are being presented at the 10th annual meeting of the American Society of Gene Therapy, being held May 30 to June 3 at the Washington State Convention & Trade Center, Seattle.

Combined with intensive chemotherapy, high dose whole-body irradiation often is given to patients with blood and lymphatic cancers to wipe out their bone marrow cells prior to subsequent transplantation of hematopoietic stem cells, bone marrow stem cells or peripheral blood progenitor stem cells. However, there is increasing concern that such high doses of radiation may have long-term negative effects on healthy tissues and organs, such as the kidney, liver and thyroid gland.

Based on previous studies showing that intravenous gene therapy delivery of the enzyme manganese superoxide dismutase (MnSOD) could protect mice from whole body irradiation, and in preparation for a potential clinical trial of systemic MnSOD in humans, the University of Pittsburgh and Stanford researchers, led by Joel S. Greenberger, M.D., professor and chair of the department of radiation oncology, University of Pittsburgh School of Medicine, delivered the human MnSOD enzyme into mouse hematopoietic progenitor cells using a newly constructed gene therapy vector called a "minicircle" plasmid.

To determine if the cells transfected with the MnSOD minicircle plasmid retained radioprotective capacity, they irradiated those cells as well as another cell line transfected with MnSOD in a full-sized plasmid. They also irradiated a parent mouse cell line that had not been transfected with MnSOD. After irradiation, the cells we
'"/>

Contact: Jim Swyers
SwyersJP@upmc.edu
412-657-4957
University of Pittsburgh Schools of the Health Sciences
1-Jun-2007


Page: 1 2

Related biology news :

1. Enzyme discovery sheds light on vitamin D
2. Enzyme Engineering XIX
3. Enzyme inhibitor produces stable disease in patients with advanced solid cell cancers
4. Enzyme shreds Alzheimers protein
5. Enzyme defect leads to hyperinsulinism
6. Eat less, weigh more? Enzyme makes lean mice susceptible to dietary fat
7. Enzyme crystal structure reveals unexpected genome repair functions
8. Enzyme inhibitors block replication of SARS virus
9. Enzyme may be target for new anti-inflammatory compounds
10. Enzyme action creates protein linked to Alzheimers disease
11. Enzyme deficiency may contribute to liver cancer, Mount Sinai research indicates

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/23/2018)... ... , ... Lajollacooks4u is proud to have hosted a variety of groups this year – both ... Illumina, Qualcomm, Hewlett Packard, Sequenom and more, have all visited the La Jolla-based venue time ... of the reason clientele return is due to Lajollacooks4u’s signature team-building format, a way for ...
(Date:8/21/2018)... ... August 20, 2018 , ... ... for biopharma R&D, today announced that Seattle-based Aptevo Therapeutics , a ... Aptevo will use the Genedata Biologics ® platform to facilitate expansion ...
(Date:8/17/2018)... ... August 16, 2018 , ... ... NXT-Dx, an established epigenetics service provider based in Gent, Belgium. NXT-Dx provides ... DNA methylation assays using pyrosequencing or Next-Generation Sequencing and Illumina’s Infinium Methylation ...
Breaking Biology News(10 mins):
(Date:9/12/2018)... (PRWEB) , ... September 10, 2018 , ... Franz ... Graph Database technology, AllegroGraph , for Knowledge Graphs, and Semantic Web Company ... AI solutions, today announced a partnership to develop the Noam Chomsky Knowledge ...
(Date:9/7/2018)... ... September 06, 2018 , ... The Discovery on Target ... of “The industry’s preeminent event on novel drug targets.” BellBrook Labs’ high throughput ... study these emerging targets in a quest to find new treatments for disease. ...
(Date:8/31/2018)... ... 29, 2018 , ... A recent expedition led by Dr. ... Institute of Industrial Science, the University of Tokyo, demonstrated how the use of ... study of hard to reach deep sea ecosystems, like intermittently active methane seeps. ...
(Date:8/29/2018)... ... August 28, 2018 , ... CEO ... of a safety study performed on an allogeneic (donor derived) stem cell product ... Association (NAVRMA) conference in September. He is also the organizer of Breakout ...
Breaking Biology Technology:
Cached News: